Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2005
10/25/2005CA2261725C Piperidine and piperazine derivatives and their use as muscarinic antagonists
10/25/2005CA2157191C Process for the hydrogenation of imines
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/25/2005CA2059882C Sulfonylureas
10/20/2005WO2005097757A2 Nucleoside derivatives and therapeutic use thereof
10/20/2005WO2005097713A1 Fluoridation method
10/20/2005WO2005097137A2 Advanced quinazoline based protein kinase inhibitors
10/20/2005WO2005097134A2 Quinazoline based protein kinase inhibitors
10/20/2005WO2005096818A1 Difluoromethanesulfonyl anilide derivatives useful as herbicides
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2004096147A3 Oxo-pyrimidine compounds
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234080 Mitotic kinesin inhibitors
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234051 5-Substituted 2-aryl-4 pyrimidinones
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005DE10393651T5 Polymerisierbare Verbindungen mit Gruppen, die vier Wasserstoffbrückenbindungen ausbilden Polymerizable compounds with groups that form four hydrogen bonds
10/20/2005CA2562965A1 Nucleoside derivatives and therapeutic use thereof
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585737A2 Uracils having a herbicidal activity
10/19/2005EP1585736A2 Process for the preparation of rosuvastatin
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585522A2 Quinazolinones as potassium channel modulators
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1385829A4 Nucleic acid labeling compounds
10/19/2005EP1194414B1 Process for preparing 2-amino-4-(4-fluorphenyl)-6-alkylpyrimidine-5-carboxylate
10/19/2005CN1683344A 4-quinazolone derivative and its use in anti-tumor medicine
10/19/2005CN1223587C Process for producing substituted aniline compound
10/18/2005US6956109 capable of crossing cell membranes, penetrating inside cells and mimicking various properties of the ceramides, particularly that of inducing apoptosis in human cancer cells
10/18/2005US6956039 Nitrogenous heterocylic compounds
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005CA2148928C Pharmacologically active pyridine derivatives and processes for the preparation thereof
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2117511C N-cyanoaryl-nitrogen heterocycles
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095360A1 Neurologically-active compounds
10/13/2005WO2005095359A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/13/2005WO2005095358A2 Process for the preparation of aminopyrimidines
10/13/2005WO2005095357A2 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005WO2005095351A1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
10/13/2005WO2005095345A2 Heteroaryl guanidines as inhibitors of viral replication
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094896A2 Targeted serotonin reuptake inhibitors
10/13/2005WO2005094878A1 Composition having antitumor effect
10/13/2005WO2005094828A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005WO2005070910A3 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
10/13/2005WO2005068468A3 Heterocyclic protein kinase inhibitors and uses thereof
10/13/2005WO2005066139A3 2-(amino-substituted)-4-aryl pyramidines and related compounds useful for treating inflammatory diseases
10/13/2005WO2005033288A3 Hedgehog pathway antagonists
10/13/2005US20050228029 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis
10/13/2005US20050228002 Anti proliferavtive agents; small molecule inhibitors of KSP(kinesin-related proteins); N-(3-aminopropyl)-N-[1-(3-benzyl-4-oxo-6,7,8 ,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-2-yl)propyl]-4-bromobenzamide
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227992 Protein kinase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050224756 3,3,4,4-Tetrafluorocyclopentane compounds, used as components of liquid crystal media
10/13/2005CA2563038A1 Neurologically-active compounds
10/13/2005CA2558915A1 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005CA2557719A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005CA2557372A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1140848B1 Phenethyl-5-bromopyridylthiourea (pbt) derivatives exhibiting spermicidal activity
10/12/2005EP1100787B1 Lipid-lowering quinazoline derivative
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/12/2005CN1681796A Process for the preparation of 4- (3'-chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681793A Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
10/12/2005CN1681774A Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2, 6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681507A New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
10/12/2005CN1680382A Preparation of tetraodotoxin by two-step resin method and tetraodotoxin preparation thereof
10/12/2005CN1680368A Process for production of substituted aniline compound
10/12/2005CN1680340A Novel triazolo pyrimidine compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1680325A Preparation of pyridine derivatives
10/12/2005CN1680310A Substituted sulfonylaminomethylbenzoic acid (derivatives) and their preparation
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953806 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/11/2005US6953803 Pyrimidine compounds
10/11/2005US6953802 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
10/11/2005US6953801 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/11/2005US6953800 Quinazoline derivatives
10/11/2005CA2282277C Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005091697A2 Thiourea compositions and uses thereof
10/06/2005US20050222426 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
10/06/2005US20050222415 Process for the preparation of rosuvastatin
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222410 Inhibitors of histone deacetylase
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 427